Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1981-04-01
1986-05-20
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514913, A61K 31225
Patent
active
045902100
ABSTRACT:
Compositions for treating ocular hypertension by topical administration containing .alpha.-methyl epinephrine, .alpha.-methyl norepinephrine, their C.sub.1 -C.sub.8 alkanoyl diesters and the pharmacologically acceptable acid addition salts thereof are disclosed.
REFERENCES:
patent: 3657244 (1972-04-01), Mentrup et al.
patent: 3705233 (1972-12-01), Lunts et al.
patent: 3732300 (1973-05-01), Lunts et al.
patent: 3808317 (1974-04-01), Hecht et al.
patent: 3809714 (1974-05-01), Hussain et al.
patent: 3839584 (1974-10-01), Hussain et al.
patent: 3868461 (1975-02-01), Hussain et al.
patent: 3937838 (1976-02-01), Hetlerlin et al.
patent: 3959485 (1976-05-01), Windheuser
Langham, "The Pharmacology of the Adrenergic Therapy of Glaucoma," International Glaucoma Symposium, ALBI (France), May 20-24, 1974, pp. 317-331.
Chem. Abst. 89, 99621(a) (1978)--Mandell.
Lewis's Pharmacology--Crossland--4th ed., 1970, pp. 381-382, 386-387.
J. Pharmacol. Exp. Therap. 161: 279-295 (1968)--Patil et al.
J. Pharm. Pharmac., 1969, 21 Suppl. 199S-205S--Farrugia et al.
JADA 92, 748-750 (1976)--Clarlone.
Annals of Ophthal. 3(3), 282-288 (1971)--Lorenzetti.
LandOfFree
Compositions for treatment of ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for treatment of ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treatment of ocular hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2109110